97 related articles for article (PubMed ID: 11899134)
1. Decreased expression of fas (APO-1/CD95) on lesional CD4+ T lymphocytes in cutaneous T cell lymphomas: correlations with blood data.
Dereure O; Portales P; Clot J; Guilhou JJ
Br J Dermatol; 2001 Dec; 145(6):1031-2. PubMed ID: 11899134
[No Abstract] [Full Text] [Related]
2. High Expression of Fas/CD95 on CD4+ Circulating T Cells: An Exclusion Criterion in the Diagnosis of Mycosis Fungoides?
Du-Thanh A; Portalès P; Serre-Cousiné A; Girard C; Guillot B; Dereure O
Acta Derm Venereol; 2017 Jul; 97(7):834-837. PubMed ID: 28206666
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of Fas (APO-1/CD95) on peripheral blood CD4+ T lymphocytes in cutaneous T-cell lymphomas.
Dereure O; Portales P; Clot J; Guilhou JJ
Br J Dermatol; 2000 Dec; 143(6):1205-10. PubMed ID: 11122022
[TBL] [Abstract][Full Text] [Related]
4. Expression of the CD4+ cell-specific chemoattractant interleukin-16 in mycosis fungoides.
Blaschke V; Reich K; Middel P; Letschert M; Sachse F; Harwix S; Neumann C
J Invest Dermatol; 1999 Oct; 113(4):658-63. PubMed ID: 10504456
[TBL] [Abstract][Full Text] [Related]
5. Immunophenotypic shift from CD4(+) to CD8(+) in mycosis fungoides.
Endo C; Naka Y; Miyagaki T; Fujita H; Sugaya M; Kawashima M; Tsunemi Y
Br J Dermatol; 2016 Oct; 175(4):830-3. PubMed ID: 27167533
[No Abstract] [Full Text] [Related]
6. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
[TBL] [Abstract][Full Text] [Related]
7. Profiles of Foxp3+ regulatory T cells in eczematous dermatitis, psoriasis vulgaris and mycosis fungoides.
Fujimura T; Okuyama R; Ito Y; Aiba S
Br J Dermatol; 2008 Jun; 158(6):1256-63. PubMed ID: 18363755
[TBL] [Abstract][Full Text] [Related]
8. In situ identification and enumeration of T lymphocytes in cutaneous T-cell lymphomas by demonstration of granular activity of acid non-specific esterase.
Sterry W; Steigleder GK; Pullmann H
Br J Dermatol; 1980 Jul; 103(1):67-72. PubMed ID: 6968580
[TBL] [Abstract][Full Text] [Related]
9. Infrequent Fas mutations but no Bax or p53 mutations in early mycosis fungoides: a possible mechanism for the accumulation of malignant T lymphocytes in the skin.
Dereure O; Levi E; Vonderheid EC; Kadin ME
J Invest Dermatol; 2002 Jun; 118(6):949-56. PubMed ID: 12060388
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of Mycosis fungoides.
Beyer M; Möbs M; Humme D; Sterry W
J Dtsch Dermatol Ges; 2011 Aug; 9(8):594-8. PubMed ID: 21371258
[TBL] [Abstract][Full Text] [Related]
11. Expression of apoptosis markers on peripheral blood lymphocytes from patients with cutaneous T-cell lymphoma during extracorporeal photochemotherapy.
Osella-Abate S; Zaccagna A; Savoia P; Quaglino P; Salomone B; Bernengo MG
J Am Acad Dermatol; 2001 Jan; 44(1):40-7. PubMed ID: 11148475
[TBL] [Abstract][Full Text] [Related]
12. Expression of Fas and Fas-ligand in primary cutaneous T-cell lymphoma (CTCL): association between lack of Fas expression and aggressive types of CTCL.
Zoi-Toli O; Vermeer MH; De Vries E; Van Beek P; Meijer CJ; Willemze R
Br J Dermatol; 2000 Aug; 143(2):313-9. PubMed ID: 10951138
[TBL] [Abstract][Full Text] [Related]
13. Dual CD4/CD8-positive Ichthyosiform Mycosis Fungoides with Lymph Node, Peripheral Blood and Cardiac Involvement: A Case Report.
Kaku Y; Otsuka A; Tanizaki H; Shibuya R; Endo Y; Nonomura Y; Hirata M; Fujimoto M; Ohmori K; Sakurai T; Kabashima K
Acta Derm Venereol; 2016 May; 96(4):564-6. PubMed ID: 26633168
[No Abstract] [Full Text] [Related]
14. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
15. Immunocytochemical characterisation of cutaneous lymphomas other than mycosis fungoides.
Ralfkiaer E; Saati TA; Bosq J; Delsol G; Gatter KC; Mason DY
J Clin Pathol; 1986 May; 39(5):553-63. PubMed ID: 3522633
[TBL] [Abstract][Full Text] [Related]
16. CD4/CD8 dual-positive mycosis fungoides: a previously unrecognized variant.
Knapp CF; Mathew R; Messina JL; Lien MH
Am J Dermatopathol; 2012 May; 34(3):e37-9. PubMed ID: 22356917
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory Vitiligo or Hypopigmented Mycosis Fungoides?
Gomez-Moyano E; Vera-Casaño A; Gamero AH; Sanz-Trelles A; Crespo-Erchiga V
J Pediatr Hematol Oncol; 2010 May; 32(4):338-9. PubMed ID: 20418787
[No Abstract] [Full Text] [Related]
18. Membrane expression of NK receptors CD160 and CD158k contributes to delineate a unique CD4+ T-lymphocyte subset in normal and mycosis fungoides skin.
Sako N; Schiavon V; Bounfour T; Dessirier V; Ortonne N; Olive D; Ram-Wolff C; Michel L; Sicard H; Marie-Cardine A; Bagot M; Bensussan A; Schmitt C
Cytometry A; 2014 Oct; 85(10):869-82. PubMed ID: 25044837
[TBL] [Abstract][Full Text] [Related]
19. The difficulties in defining follicular T helper phenotype in cutaneous lymphomas.
Guitart J; Gammon B
Am J Dermatopathol; 2013 Aug; 35(6):691. PubMed ID: 23334519
[No Abstract] [Full Text] [Related]
20. Mycosis fungoides following skin trauma.
Paul LJ; Duvic M
J Am Acad Dermatol; 2012 Oct; 67(4):e148. PubMed ID: 22980272
[No Abstract] [Full Text] [Related]
[Next] [New Search]
